|Last Price$80.48||Day Change (%)0.68%|
|Open Price$80.88||Day Change ($)0.54|
|Day Range79.85–80.88||52-Week Range64.64–85.72|
As of Thu 12/18/2014 06:34 PM EST | USD
Express Scripts Names New Chief Financial Officer
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
The wide-moat pharmacy benefit manager is still undervalued.
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...
While the sector looks fairly valued overall, we still see several stocks that offer attractive valuations across the different industries, including pharmacy benefit managers.
Despite full valuations overall, we do see some opportunities, especially in pharmacy benefit managers.